Cryptococcal Optimal ART Timing Trial
clinical trial
Press Enter · cited answer in seconds
0 sources
Cryptococcal Optimal ART Timing Trial
Summary
Cryptococcal Optimal ART Timing Trial is a clinical trial[1].
Key Facts
- Cryptococcal Optimal ART Timing Trial is in the country of South Africa[2].
- Cryptococcal Optimal ART Timing Trial is in the country of Uganda[3].
- Cryptococcal Optimal ART Timing Trial's instance of is recorded as clinical trial[4].
- Cryptococcal Optimal ART Timing Trial's start time is recorded as +2010-11-30T00:00:00Z[5].
- Cryptococcal Optimal ART Timing Trial's end time is recorded as +2012-10-31T00:00:00Z[6].
- Cryptococcal Optimal ART Timing Trial's main subject is recorded as HIV[7].
- Cryptococcal Optimal ART Timing Trial's main subject is recorded as meningitis[8].
- Cryptococcal Optimal ART Timing Trial's number of participants is recorded as {'unit': '1', 'amount': '+177'}[9].
- Cryptococcal Optimal ART Timing Trial's title is recorded as Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis[10].
- Cryptococcal Optimal ART Timing Trial's short name is recorded as COAT[11].
- Cryptococcal Optimal ART Timing Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+14'}[12].
- Cryptococcal Optimal ART Timing Trial's ClinicalTrials.gov ID is recorded as NCT01075152[13].
- Cryptococcal Optimal ART Timing Trial's research intervention is recorded as lamivudine[14].
- Cryptococcal Optimal ART Timing Trial's research intervention is recorded as efavirenz[15].
- Cryptococcal Optimal ART Timing Trial's clinical trial phase is recorded as phase IV clinical trial[16].
- Cryptococcal Optimal ART Timing Trial's research site is recorded as Mbarara University of Science and Technology[17].
- Cryptococcal Optimal ART Timing Trial's research subject recruitment status is recorded as completed[18].
- Cryptococcal Optimal ART Timing Trial's study type is recorded as interventional study[19].